Researchers at iStopMM have for the first time described the prevalence of smoldering multiple myeloma and the findings indicate that it is present in 0.5% of people over 40. The high prevalence of smoldering multiple myeloma has implications for future treatment policies in multiple myeloma because people with this precursor condition, in cases where it has a high chance of developing into malignant multiple myeloma, will probably be invited to start drug treatment in the next few years. The results of the study were recently published in Nature Medicine. See further.
Multiple Myeloma Hub‘s summary of the iStopMM key talks and posters at ASH 2021
February 11, 2022
The Multiple Myelome Hub has provided a good summary of the key talks and posters from the iStopMM team at the 63rd American Society of
